A detailed history of Nomura Holdings Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 8,443 shares of ARVN stock, worth $161,092. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,443
Holding current value
$161,092
% of portfolio
0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.66 - $32.73 $199,761 - $276,339
8,443 New
8,443 $207,000
Q3 2022

Nov 15, 2022

SELL
$41.87 - $57.99 $1.96 Million - $2.71 Million
-46,722 Reduced 26.44%
129,963 $5.79 Million
Q2 2022

Aug 15, 2022

SELL
$36.01 - $74.24 $3.35 Million - $6.92 Million
-93,147 Reduced 34.52%
176,685 $7.52 Million
Q1 2022

May 18, 2022

SELL
$60.27 - $81.57 $1.53 Million - $2.07 Million
-25,325 Reduced 8.58%
269,832 $18.9 Million
Q4 2021

Feb 14, 2022

BUY
$65.85 - $96.21 $758,921 - $1.11 Million
11,525 Added 4.06%
295,157 $24.2 Million
Q3 2021

Nov 15, 2021

BUY
$73.2 - $107.87 $768,600 - $1.13 Million
10,500 Added 3.84%
283,632 $24 Million
Q2 2021

Aug 16, 2021

SELL
$60.45 - $84.26 $3.35 Million - $4.68 Million
-55,500 Reduced 16.89%
273,132 $21 Million
Q1 2021

May 17, 2021

SELL
$58.19 - $91.37 $2.36 Million - $3.7 Million
-40,472 Reduced 10.96%
328,632 $21.8 Million
Q4 2020

Feb 16, 2021

BUY
$20.19 - $84.93 $6.92 Million - $29.1 Million
342,757 Added 1300.93%
369,104 $31.3 Million
Q3 2020

Nov 12, 2020

BUY
$22.99 - $36.34 $605,717 - $957,449
26,347 New
26,347 $626,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.